Physician profile
Darryl E Glover
NPI 1487935995
$44,307.28
in general payments reported to CMS, 2019-2025
19 companies · $2,588 in 2025
The $2,588 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,237 · 2020: $981 · 2021: $6,585 · 2022: $13K · 2023: $6,807 · 2024: $11K · 2025: $2,588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,500 · Food and Beverage: $3,369 · Travel and Lodging: $2,110 · Education: $7.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,982.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,500.00 |
| Food and Beverage | $3,368.74 |
| Travel and Lodging | $2,109.76 |
| Education | $7.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $24,146.39 | 2019-2025 | Total30, Precision 1, Dailies Total1 |
| Allergan, INC. | $7,666.38 | 2021-2022 | |
| Johnson & Johnson Vision Care, INC. | $4,376.78 | 2019-2025 | Acuvue |
| Abbvie INC. | $2,946.26 | 2022-2023 | |
| Tarsus Pharmaceuticals, INC. | $939.74 | 2024-2025 | Xdemvy |
| Carl Zeiss Meditec, INC. | $920.00 | 2020 | |
| Bausch & Lomb Americas INC. | $912.61 | 2022-2025 | Xiidra, Miebo, Infuse |
| Coopervision INC. | $810.93 | 2019-2025 | Clariti Contact Lens, Misight Contact Lens, Myday Contact Lens |
| Alcon Research LLC | $665.00 | 2022 | |
| Dompe US, INC. | $215.66 | 2022-2025 | Oxervate |
| The Walman Optical Company | $153.09 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $122.92 | 2019-2020 | |
| Harrow Eye, LLC | $122.21 | 2024-2025 | Vevye |
| Novartis Pharmaceuticals Corporation | $121.02 | 2022-2023 | |
| Quidel Corporation | $70.26 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $51.02 | 2022-2025 | |
| Carl Zeiss Meditec USA, INC. | $28.35 | 2023 | |
| Becton, Dickinson and Company | $21.00 | 2019 | |
| Kala Pharmaceuticals, INC. | $17.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darryl Glover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.